Day One Biopharmaceutical Stock (NASDAQ: DAWN)

Day One Biopharmaceutical (NASDAQ:DAWN) Stock, Quote.MetaTitle.unusual-options

Day One Biopharmaceutical

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceuticals Inc

Dawn Protocol

DAWNRAYS PHARM HLDGS LTD by Dawnrays Pharmaceutical Holdings, Ltd.

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

AnaptysBio

ArriVent BioPharma

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

Bicara Therapeutics

Biohaven

CareDx

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Gyre Therapeutics

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Kodiak Sciences

Kura Oncology

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

Nanobiotix

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Organogenesis Holdings

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Rezolute

Sana Biotechnology

ARS Pharmaceuticals

Savara

Tango Therapeutics

Tyra Biosciences

Valneva

Xencor

Prévisions Day One Biopharmaceutical (DAWN)

Actualités

Gains

Quote.Nav.option-chain

Évaluations des analystes

Transactions internes

Intérêt court

Rapport sur les stocks

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Comments

Day One Biopharmaceutical Options Inhabitueles

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL